Why the study?
Patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass are at high risk of lethal complications and present specific management challenges.
Population
Patients suffering from heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass
Design
Review
Authors
Loading...
HIT management in CPB remains challenging; leaves open optimal strategies pending higher-level evidence.
This review provides an institutional protocol and strategies for safely managing anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Revelly et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: